The BCR-ABLp210 fusion gene (also termed BCR-ABL1) arises from the t(9; 22) (q34; q11) reciprocal translocation, is characteristic of chronic myeloid leukemia (CML), and the chimeric protein has constitutive kinase activity. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.